419 filings
Page 3 of 21
8-K
IMVT
Immunovant Inc
28 Nov 23
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
7:43am
4
IMVT
Immunovant Inc
24 Nov 23
Immunovant / Peter Salzmann ownership change
2:55pm
4
Eva Renee Barnett
24 Nov 23
Immunovant / Eva Renee Barnett ownership change
2:51pm
4
Butchko Julia G.
24 Nov 23
Immunovant / Julia G. Butchko ownership change
2:47pm
4
IMVT
Immunovant Inc
24 Nov 23
Immunovant / William L. Macias ownership change
2:45pm
4
Mark S. Levine
24 Nov 23
Immunovant / Mark S. Levine ownership change
2:41pm
S-3ASR
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
10-Q
2024 Q2
IMVT
Immunovant Inc
Quarterly report
9 Nov 23
7:13am
8-K
IMVT
Immunovant Inc
9 Nov 23
Results of Operations and Financial Condition
7:06am
4
IMVT
Immunovant Inc
27 Oct 23
Immunovant / Mark S. Levine ownership change
4:04pm
4
William L. Macias
20 Oct 23
Immunovant / William L. Macias ownership change
4:06pm
4
Eva Renee Barnett
11 Oct 23
Immunovant / Eva Renee Barnett ownership change
4:11pm
4
Butchko Julia G.
6 Oct 23
Immunovant / Julia G. Butchko ownership change
5:15pm
4
IMVT
Immunovant Inc
6 Oct 23
Immunovant / Peter Salzmann ownership change
5:10pm
SC 13D/A
IMVT
Immunovant Inc
4 Oct 23
Immunovant / Roivant Sciences ownership change
5:19pm
4
ROIV
Roivant Sciences Ltd
4 Oct 23
Change in insider ownership
5:15pm
424B5
IMVT
Immunovant Inc
29 Sep 23
Prospectus supplement for primary offering
4:48pm
8-K
IMVT
Immunovant Inc
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
FWP
IMVT
Immunovant Inc
28 Sep 23
Free writing prospectus
6:09am
FWP
IMVT
Immunovant Inc
26 Sep 23
Free writing prospectus
8:00pm